Literature DB >> 2479273

Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.

P E van Erp1, J J Rijzewijk, J B Boezeman, J Leenders, S de Mare, J Schalkwijk, P C van de Kerkhof, F C Ramaekers, F W Bauer.   

Abstract

Keratin-type intermediate filament proteins show characteristic expression in normal and pathologic epidermis. Some keratins are restricted to the basal cell layers, and others occur exclusively in the suprabasal compartment. SDS-gel-electrophoresis and immunohistochemistry are generally used for the assessment of keratin profiles and their localizations. In the present investigation, flow cytometric analysis of four different monoclonal antibodies (MAb) against intermediate filament-type proteins, in addition to measurement of relative DNA content, was performed on cell suspensions derived from lesional and clinically uninvolved skin of psoriatic patients and from skin of healthy controls. MAb Ks8.12, reacting with keratins 13 and 16, was used as a marker for hyperproliferation. Pab601 recognizes the basal cell layer(s) of human epidermis. Keratin 10 expression as a marker of keratinization was quantified with RKSE60 and the anti-vimentin MAb MVI was used as a marker for non-keratinocytes. Psoriatic skin showed significantly reduced numbers of RKSE60-positive cells and MVI-positive cells compared with normal skin. In contrast to normal skin and uninvolved skin of psoriatic patients in which only a minority of the cells were Ks8.12 positive, up to 60% of the cell population in psoriatic lesions bound with MAb. Simultaneous measurement of relative DNA content and MAb binding showed that Pab601 binding was associated with cells in S-phase and G2M-phase of the cell cycle, whereas RKSE60 and Ks8.12 binding were associated with diploid cells. Multiparameter flow cytometry allows quantitative population analysis that could lead to a better understanding of the complex mechanisms of epidermal growth control under normal and pathologic conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479273      PMCID: PMC1880099     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  21 in total

1.  Simultaneous cell cycle analysis and two-color surface immunofluorescence using 7-amino-actinomycin D and single laser excitation: applications to study of cell activation and the cell cycle of murine Ly-1 B cells.

Authors:  P S Rabinovitch; R M Torres; D Engel
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

2.  Monoclonal antibodies for epidermal population analysis.

Authors:  F W Bauer; J B Boezeman; L van Engelen; R M de Grood; F C Ramaekers
Journal:  J Invest Dermatol       Date:  1986-07       Impact factor: 8.551

3.  Differentiation-related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn, and adult epidermis.

Authors:  G N Van Muijen; S O Warnaar; M Ponec
Journal:  Exp Cell Res       Date:  1987-08       Impact factor: 3.905

4.  Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.

Authors:  S de Mare; P E Van Erp; P C van de Kerkhof
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

5.  Changes in keratin gene expression during terminal differentiation of the keratinocyte.

Authors:  E Fuchs; H Green
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

6.  Flow cytometry as a tool for the study of cell kinetics in epidermis.

Authors:  F W Bauer; N H Crombag; R M de Grood; G J de Jongh
Journal:  Br J Dermatol       Date:  1980-06       Impact factor: 9.302

7.  The expression of keratin genes in epidermis and cultured epidermal cells.

Authors:  E Fuchs; H Green
Journal:  Cell       Date:  1978-11       Impact factor: 41.582

8.  Protein modifications during the keratinization of normal and psoriatic human epidermis.

Authors:  D Skerrow; I Hunter
Journal:  Biochim Biophys Acta       Date:  1978-12-20

9.  Two tris urea mercaptoethanol extractable polypeptides found uniquely in scales of patients with psoriasis.

Authors:  M P Thaler; K Fukuyama; N Inoue; D L Cram; W L Epstein
Journal:  J Invest Dermatol       Date:  1978-01       Impact factor: 8.551

10.  Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization.

Authors:  R Kopan; G Traska; E Fuchs
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

View more
  6 in total

1.  Keratin 17: a useful marker in anti-psoriatic therapies.

Authors:  E M de Jong; I M van Vlijmen; P E van Erp; F C Ramaekers; S M Troyanovski; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Multiparameter flow cytometric characterization of epidermal cell suspensions prepared from normal and hyperproliferative human skin using an optimized thermolysin-trypsin protocol.

Authors:  C P Glade; B A Seegers; E F Meulen; C A van Hooijdonk; P E van Erp; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

3.  The growth and differentiation of human keratinocytes in vitro: a combined immunohistochemical and flow cytometric study.

Authors:  P E van Erp; G J de Jongh; J B Boezeman; J Schalkwijk
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

4.  Flow cytometric quantification of human epidermal cells expressing keratin 16 in vivo after standardized trauma.

Authors:  S de Mare; P E van Erp; F C Ramaekers; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

5.  The relationship between preoperative clinical scores and immunohistological evaluation of surgically resected tissues in chronic severe ocular surface diseases.

Authors:  Hidetoshi Tanioka; Satoshi Kawasaki; Chie Sotozono; Takahiro Nakamura; Tsutomu Inatomi; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

6.  MON-150, a versatile monoclonal antibody against involucrin: characterization and applications.

Authors:  J L van Duijnhoven; J Schalkwijk; M H Kranenborg; I M van Vlijmen-Willems; A Groeneveld; P E van Erp; E D Timmer; G J de Jongh; W J van de Ven
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.